Literature DB >> 21157318

H1N1: viral pneumonia as a cause of acute respiratory distress syndrome.

Clare Ramsey1, Anand Kumar.   

Abstract

PURPOSE OF REVIEW: To review the literature on novel swine origin influenza A (H1N1 2009) as a cause of respiratory failure and acute respiratory distress syndrome (ARDS). RECENT
FINDINGS: H1N1 2009 was first recognized as a pathogen in March of 2009, when there was a spike in the number of cases of influenza-like illness leading to severe and at times fatal pneumonia. The etiologic agent was then identified as a novel H1N1 influenza A virus, which subsequent spread rapidly throughout the globe. Most countries reported cases of severe viral pneumonitis requiring intensive care unit (ICU) admission. Severe disease was noted to occur more commonly in younger patients than those typically affected by seasonal influenza and obesity and pregnancy were associated with severe disease. The majority of patients requiring ICU admission met criteria for ARDS and case fatality ratio was estimated at less than 0.5%. Chest radiographs and pathology resembled ARDS and most patients were treated with low tidal volume ventilation, high positive end expiratory pressure and at times, rescue therapies. Available evidence suggests that early antiviral treatment improves outcomes from H1N1 2009.
SUMMARY: H1N1 2009 has emerged as an important cause of ARDS in 2009-2010. Prompt recognition and treatment with antivirals improves outcomes.

Entities:  

Mesh:

Year:  2011        PMID: 21157318     DOI: 10.1097/MCC.0b013e3283427259

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  25 in total

1.  Distal airway stem cells yield alveoli in vitro and during lung regeneration following H1N1 influenza infection.

Authors:  Pooja A Kumar; Yuanyu Hu; Yusuke Yamamoto; Neo Boon Hoe; Tay Seok Wei; Dakai Mu; Yan Sun; Lim Siew Joo; Rania Dagher; Elisabeth M Zielonka; De Yun Wang; Bing Lim; Vincent T Chow; Christopher P Crum; Wa Xian; Frank McKeon
Journal:  Cell       Date:  2011-10-28       Impact factor: 41.582

2.  Critical role of CXCL4 in the lung pathogenesis of influenza (H1N1) respiratory infection.

Authors:  L Guo; K Feng; Y C Wang; J J Mei; R T Ning; H W Zheng; J J Wang; G S Worthen; X Wang; J Song; Q H Li; L D Liu
Journal:  Mucosal Immunol       Date:  2017-01-25       Impact factor: 7.313

3.  Viral invasion of the amniotic cavity (VIAC) in the midtrimester of pregnancy.

Authors:  Maria-Teresa Gervasi; Roberto Romero; Gabriella Bracalente; Tinnakorn Chaiworapongsa; Offer Erez; Zhong Dong; Sonia S Hassan; Lami Yeo; Bo Hyun Yoon; Gil Mor; Luisa Barzon; Elisa Franchin; Valentina Militello; Giorgio Palù
Journal:  J Matern Fetal Neonatal Med       Date:  2012-05-30

4.  IL-22 is essential for lung epithelial repair following influenza infection.

Authors:  Derek A Pociask; Erich V Scheller; Sivanarayana Mandalapu; Kevin J McHugh; Richard I Enelow; Cheryl L Fattman; Jay K Kolls; John F Alcorn
Journal:  Am J Pathol       Date:  2013-03-11       Impact factor: 4.307

5.  Identification of a nerve-associated, lung-resident interstitial macrophage subset with distinct localization and immunoregulatory properties.

Authors:  Basak B Ural; Stephen T Yeung; Payal Damani-Yokota; Joseph C Devlin; Maren de Vries; Paola Vera-Licona; Tasleem Samji; Catherine M Sawai; Geunhyo Jang; Oriana A Perez; Quynh Pham; Leigh Maher; P'ng Loke; Meike Dittmann; Boris Reizis; Kamal M Khanna
Journal:  Sci Immunol       Date:  2020-03-27

6.  Renal Replacement Therapy in Patients with Influenza Pneumonia Related Acute Respiratory Distress Syndrome.

Authors:  Ko-Wei Chang; Shaw-Woei Leu; Shih-Wei Lin; Shinn-Jye Liang; Kuang-Yao Yang; Ming-Cheng Chan; Wei-Chih Chen; Han-Chung Hu; Wen-Feng Fang; Yu-Mu Chen; Chau-Chyun Sheu; Ming-Ju Tsai; Hao-Chien Wang; Ying-Chun Chien; Chung-Kan Peng; Chieh-Liang Wu; Kuo-Chin Kao
Journal:  J Clin Med       Date:  2021-04-23       Impact factor: 4.241

7.  Essential role of IL-6 in protection against H1N1 influenza virus by promoting neutrophil survival in the lung.

Authors:  O Dienz; J G Rud; S M Eaton; P A Lanthier; E Burg; A Drew; J Bunn; B T Suratt; L Haynes; M Rincon
Journal:  Mucosal Immunol       Date:  2012-02-01       Impact factor: 7.313

8.  Acute respiratory damage in patients with pandemic 2009 AH1N1 influenza: Pulmonary function testing a year after?

Authors:  Nozha Brahmi; Aymen M'rad; Hatem El Ghord; Nadia Kouraichi; Hafedh Thabet; Mouldi Amamou
Journal:  Ann Thorac Med       Date:  2011-10       Impact factor: 2.219

9.  Direct association between pharyngeal viral secretion and host cytokine response in severe pandemic influenza.

Authors:  Raquel Almansa; Andres Anton; Paula Ramirez; Ignacio Martin-Loeches; David Banner; Tomás Pumarola; Luoling Xu; Jesús Blanco; Longsi Ran; Guillermo Lopez-Campos; Fernando Martin-Sanchez; Lorenzo Socias; Ana Loza; David Andaluz; Enrique Maravi; Mónica Gordón; Maria C Gallegos; Victoria Fernandez; Cristobal León; Pedro Merino; Maria Angeles Marcos; Francisco Gandía; Felipe Bobillo; Salvador Resino; Jose M Eiros; Carmen Castro; Paula Mateo; Milagros Gonzalez-Rivera; Jordi Rello; Raul Ortiz de Lejarazu; David J Kelvin; Jesus F Bermejo-Martin
Journal:  BMC Infect Dis       Date:  2011-08-31       Impact factor: 3.090

10.  Relative cost and outcomes in the intensive care unit of acute lung injury (ALI) due to pandemic influenza compared with other etiologies: a single-center study.

Authors:  Jonathan Wiesen; John J Komara; Esteban Walker; Herbert P Wiedemann; Jorge A Guzman
Journal:  Ann Intensive Care       Date:  2012-08-28       Impact factor: 6.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.